DIN 02541769 — EVKEEZA 150 MG
EVKEEZA is a solution of Evinacumab marketed by ULTRAGENYX PHARMACEUTICAL INC. The full Evinacumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02541769
- Brand name
- EVKEEZA
- Active ingredient
- Evinacumab
- Strength
- 150 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- ULTRAGENYX PHARMACEUTICAL INC
- Health Canada status
- MARKETED
- Drug class
- Angiopoietin-like protein 3 (ANGPTL3) inhibitor (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.